http://raptiva.legalview.com/msn/ 2012-02-23 http://raptiva.legalview.com/msn/sangamo-biosciences-appoints-dr-stephen-g-dilly-to/1158189/ 2012-02-23 http://raptiva.legalview.com/msn/xoma-reports-2009-third-quarter-financial-results/1131221/ 2012-02-23 http://raptiva.legalview.com/msn/fda-risks-of-life-threatening-infections-for-psoriasis-drug-raptiva/1131220/ 2012-02-23 http://raptiva.legalview.com/msn/fda-psoriasis-drug-may-be-linked-to-3-deaths/1108159/ 2012-02-23 http://raptiva.legalview.com/msn/european-medicines-agency-recommends-suspension-of-the-marketing/1108158/ 2012-02-23 http://raptiva.legalview.com/msn/fdas-medwatch-safety-alerts-march-2009/1108157/ 2012-02-23 http://raptiva.legalview.com/msn/psoriasis-drug-removed-from-market-mark-associates-pc-offering/1108156/ 2012-02-23 http://raptiva.legalview.com/msn/psoriasis-drug-raptiva-pulled-from-us-market/1108155/ 2012-02-23 http://raptiva.legalview.com/msn/efalizumab-withdrawn-from-us-market/1108154/ 2012-02-23 http://raptiva.legalview.com/msn/genentech-removing-raptiva-from-us-market/1108153/ 2012-02-23 http://raptiva.legalview.com/msn/eighth-tysabri-patient-falls-ill/1108152/ 2012-02-23 http://raptiva.legalview.com/msn/savient-saves-and-moves-up/1108151/ 2012-02-23 http://raptiva.legalview.com/msn/central-florida-defective-drug-lawyers-alert-raptiva-psoriasis-drug/1108150/ 2012-02-23 http://raptiva.legalview.com/msn/iguardorg-expands-reach-of-medication-safety-alerts-and-recalls-to/1108149/ 2012-02-23 http://raptiva.legalview.com/msn/reportlinker-adds-autoimmune-disease-therapeutics/1108148/ 2012-02-23 http://raptiva.legalview.com/msn/register-for-free/1108147/ 2012-02-23 http://raptiva.legalview.com/msn/autoimmune-disease-therapeutics-continue-to-improve-but-many/1108146/ 2012-02-23 http://raptiva.legalview.com/msn/those-with-psoriasis-at-risk-for-disease/1108145/ 2012-02-23 http://raptiva.legalview.com/msn/xoma-reports-2009-second-quarter-financial-results/1108144/ 2012-02-23